Prostaglandin Analogues for the Treatment of Glaucoma and Ocular Hypertension: A Systematic Review of Economic Evidence

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.24, Iss.8, 2006-01, pp. : 743-750

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prostaglandin Analogues in the Treatment of Glaucoma

By Lindén C.

Drugs & Aging, Vol. 14, Iss. 5, 1999-05 ,pp. : 387-398

Adis International

Access to resources Recommend Favorite

The Economic Burden of Glaucoma and Ocular Hypertension: Implications for Patient Management: A Review

By Rouland Jean-François

Drugs & Aging, Vol. 22, Iss. 4, 2005-01 ,pp. : 315-321

Adis International

Access to resources Recommend Favorite

Modeling of LIM-Kinase 2 Inhibitory Activity of Pyrrolopyrimidine Analogues: Useful in Treatment of Ocular Hypertension and Glaucoma

Medicinal Chemistry, Vol. 9, Iss. 3, 2013-05 ,pp. : 402-409

Bentham Science Publishers

Access to resources Recommend Favorite

Ocular Carteolol: A Review of its Use in the Management of Glaucoma and Ocular Hypertension

By Henness Sheridan Tracy Swainston Harrison Keating Gillian M.

Drugs & Aging, Vol. 24, Iss. 6, 2007-01 ,pp. : 509-528

Adis International

Access to resources Recommend Favorite

Topical Dorzolamide 2%/Timolol 0.5% Ophthalmic Solution: A Review of its Use in the Treatment of Glaucoma and Ocular Hypertension

By Frampton James E. Perry Caroline M.

Drugs & Aging, Vol. 23, Iss. 12, 2006-01 ,pp. : 977-995

Adis International

Access to resources Recommend Favorite